sábado, 26 de septiembre de 2020

Fact Sheet for Healthcare Providers: Clear Dx SARS-CoV-2 Test | NLM

Disaster Information Management Research Center | NLM

Disaster Information and Emergency Response

09/23/2020 12:00 AM EDT


Source: U.S. Food and Drug Administration (FDA). Published: 9/23/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Clear Dx SARS-CoV-2 Test. The Clear Dx SARS-CoV-2 Test is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)

No hay comentarios: